We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 13, 2017

MILLER v. GALENA BIOPHARMA, INC. et al

Track this case

Case Number:

2:17-cv-00929

Court:

New Jersey

Nature of Suit:

850(Securities/Commodities)

Multi Party Litigation:

Class Action

Judge:

Kevin McNulty

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 21, 2018

    Galena Investors' Stock-Drop Suit Gets Axed, For Now

    A New Jersey federal judge on Tuesday tossed a putative securities class action that claims Galena Biopharma Inc. and its top brass hid from investors that revenues from the company's pain drug Abstral were driven by an illegal off-label prescription business, finding the investors’ liability theory unclear but giving them a chance to fix the issue.


Parties

To view the parties, register now.